CCL2, Human (Carlumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-CCL2, Human (Carlumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCCL2, Human (Carlumab biosimilar)
CloneCarlumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG1 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
Applicationsn/a
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human CCL2 Recombinant Antibody. Carlumab (alternate identifier CNTO 888) is a discontinued human recombinant monoclonal antibody (type IgG1 kappa) that targets human CC chemokine ligand 2 (CCL2)/monocyte chemoattractant protein (MCP1). Carlumab was under development for use in the treatment of oncology and immune indications and was studied for application in systemic sclerosis, atherosclerosis, diabetic nephropathy, liver fibrosis and type 2 diabetes.
Immunogenn/a
Other NamesAnti-CCL2 Recombinant Antibody, Research Grade Carlumab, Anti-Human CCL2 Recombinant Antibody, CNTO 888, Antibody Drug Analogues, Monoclonal Antibody, YR1239, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 915404-94-3
Catalog #YR1239
Priceplease inquire
Order / More InfoCCL2, Human (Carlumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.